☰

Komal Rathi - Publications

Affiliations: 
2016- Biomedical and Health Informatics Children’s Hospital of Philadelphia / University of Pennsylvania, Philadelphia, PA, United States 
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Weiner AK, Radaoui AB, Tsang M, Martinez D, Sidoli S, Conkrite KL, Delaidelli A, Modi A, Rokita JL, Patel K, Lane MV, Zhang B, Zhong C, Ennis B, Miller DP, ... ... Rathi KS, et al. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Biorxiv : the Preprint Server For Biology. PMID 38106022 DOI: 10.1101/2023.12.06.570390  0.359
2022 Krytska K, Casey CE, Pogoriler J, Martinez D, Rathi KS, Farrel A, Berko ER, Tsang M, Sano RR, Kendsersky N, Erickson SW, Teicher BA, Isse K, Saunders L, Smith MA, et al. Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma. Cancer Research Communications. 2: 616-623. PMID 36381237 DOI: 10.1158/2767-9764.crc-22-0137  0.33
2021 Dang MT, Gonzalez MV, Gaonkar KS, Rathi KS, Young P, Arif S, Zhai L, Alam Z, Devalaraja S, To TKJ, Folkert IW, Raman P, Rokita JL, Martinez D, Taroni JN, et al. Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality. Cell Reports. 34: 108917. PMID 33789113 DOI: 10.1016/j.celrep.2021.108917  0.319
2021 Shields CE, Potlapalli S, Cuya-Smith SM, Chappell SK, Chen D, Martinez D, Pogoriler J, Rathi KS, Patel SA, Oristian KM, Linardic CM, Maris JM, Haynes KA, Schnepp RW. Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Molecular Oncology. PMID 33523558 DOI: 10.1002/1878-0261.12914  0.307
2020 Lopez G, Conkrite KL, Doepner M, Rathi KS, Modi A, Vaksman Z, Farra L, Hyson E, Noureddine M, Wei JS, Smith MA, Asgharzadeh S, Seeger R, Khan JS, Guidry Auvil JM, et al. Somatic structural variation targets neurodevelopmental genes and identifies as a tumor suppressor in neuroblastoma. Genome Research. PMID 32796005 DOI: 10.1101/Gr.252106.119  0.316
2020 McDonald JT, Stainforth R, Miller J, Cahill T, da Silveira WA, Rathi KS, Hardiman G, Taylor D, Costes SV, Chauhan V, Meller R, Beheshti A. NASA GeneLab Platform Utilized for Biological Response to Space Radiation in Animal Models. Cancers. 12. PMID 32045996 DOI: 10.3390/Cancers12020381  0.41
2020 Nabbi A, Sun P, Sumedha S, Zhu K, Yang SYC, Paulson JN, Kool M, Rathi K, Kalletla K, Raman P, Zhu Y, Resnick AC, Jones DTW, Jäger N, Pfister SM, et al. Abstract PR06: The immunogenomic landscape of pediatric primary solid tumors Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-Pr06  0.417
2020 Chen D, Cox J, Annam J, Weingart M, Essien G, Rathi K, Khurana P, Cuya S, Harenza JL, Bosse K, Pilgrim A, Maris JM, Schnepp RW. Abstract B48: A LIN28B-PDZ kinase axis promotes neuroblastoma metastasis Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-B48  0.427
2020 Shields CE, Cuya SM, Chappell S, Rathi K, Patel S, Potlapalli S, Schnepp RW. Abstract A47: BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A47  0.422
2019 Raman P, Zimmerman S, Rathi KS, de Torrenté L, Sarmady M, Wu C, Leipzig J, Taylor DM, Tozeren A, Mar JC. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genetics. 235: 1-12. PMID 31296308 DOI: 10.1016/J.Cancergen.2019.04.004  0.473
2019 Cuya SM, Pilgrim A, Rathi K, Chen D, Schnepp R. Abstract 3669: Defining an ELAVL1-Musashi 2 signaling cascade in neuroblastoma tumorigenesis Cancer Research. 79: 3669-3669. DOI: 10.1158/1538-7445.Sabcs18-3669  0.432
2019 Shields CE, Cuya SM, Chappell SK, Rathi K, Patel S, Potlapalli S, Schnepp RW. Abstract 3838: Targeting epigenetic regulator BMI-1 in alveolar rhabdomyosarcoma Cancer Research. 79: 3838-3838. DOI: 10.1158/1538-7445.Am2019-3838  0.419
2019 Weiner AK, Radaoui AB, Kendsersky NM, Harenza-Rokita JL, Sidoli S, Conkrite KL, Vaksman Z, Rathi K, Raman P, Martinez D, Bhatti T, Tsang M, Pawel B, Garcia BA, Maris JM, et al. Abstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma Cancer Research. 79: 3650-3650. DOI: 10.1158/1538-7445.Am2019-3650  0.394
2019 Lenzen A, Lauing KL, Zhai L, Ladomersky E, Raman P, Rathi K, Lulla RR, Hashizume R, Wainwright DA. IMMU-01. NOVEL RNA-TARGETING STRATEGY FOR TREATING T CELL-DRIVEN IMMUNOSUPPRESSION IN HUMAN DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 21: ii92-ii93. DOI: 10.1093/Neuonc/Noz036.122  0.304
2018 Raman P, Rathi K, Kalletla K, Zhu Y, Zhang B, Cros A, Nazarian J, Waanders AJ, Mueller S, Storm PB, Resnick AC. TBIO-28. DISEASEXPRESS, A CANCER DATA ANALYTICS AND VISUALIZATION TOOL FOR IDENTIFYING IMMUNOTHERAPEUTIC TARGETS IN PEDIATRIC BRAIN TUMORS AND OTHER CANCERS Neuro-Oncology. 20: i186-i186. DOI: 10.1093/Neuonc/Noy059.716  0.332
2017 Bosse KR, Raman P, Lane M, Sussman RT, Harenza JL, Martinez D, Heitzeneder S, Zhu Z, Rathi K, Randall M, Donovan L, Morrissy S, Zhelev DV, Feng Y, Hwang J, et al. Abstract 685: GPC2 is an oncogene and immunotherapeutic target in high-risk neuroblastoma Cancer Research. 77: 685-685. DOI: 10.1158/1538-7445.Am2017-685  0.433
Show low-probability matches.